OncoSenX
ID: 5329127OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
5
Funding Rounds
$19.7m
Money raised
Recent Funding Rounds
Overview
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
- Website:
- Business model: B2C B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma***** Sc**** |
|
- |
Funding series
Funding Series Analysis
The company OncoSenX has raised a total of $3m in funding over 5 rounds.
Key Insights:
- OncoSenX , July 2019: $3m
- OncoSenX Pre Seed Funding Round July 2019: $3m
- OncoSenX Pre Seed Funding Round April 2020: $4.5m
- OncoSenX, Inc. funding round, August 2021: $5m
- OncoSenX Grant July 2020: $4.2m
Industries
OncoSenX is active in the following industries: